Filing Details
- Accession Number:
- 0001209191-23-051766
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-10-03 21:00:19
- Reporting Period:
- 2023-10-02
- Accepted Time:
- 2023-10-03 21:00:19
- Original Submission Date:
- 2023-10-02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1674282 | Michael Castagna | 1 Casper Street Danbury CT 06810 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Disposition | 2023-10-02 | 10,000 | $4.08 | 2,359,147 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022.
- Correction of price.
Billionaire Hedge Funds
